Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV Jan 9, 2026 09:00AM
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV Dec 26, 2025 09:00AM
Processa Pharmaceuticals Inc. (PCSA) halted on volatility Dec 17, 2025 03:12PM
Processa Pharmaceuticals (PCSA) PT Lowered to $1 at H.C. Wainwright Sep 2, 2025 06:56AM
Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV Jul 18, 2025 08:30AM


Jul 3, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Processa Pharmaceuticals (PCSA)
Jun 30, 2025 06:49AM Processa Pharmaceuticals (PCSA) PT Lowered to $2 at H.C. Wainwright
Jun 17, 2025 09:02AM Processa Pharmaceuticals Inc. (PCSA) Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
May 30, 2025 09:01AM Processa Pharmaceuticals Inc. (PCSA) announces three abstracts for ASCO 2025
Oct 3, 2024 07:05AM H.C. Wainwright Reiterates Buy Rating on Processa Pharmaceuticals (PCSA)
Aug 28, 2024 08:04AM Processa Pharmaceuticals (PCSA) Provides Product Pipeline and Financial Update
Aug 20, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Processa Pharmaceuticals (PCSA)
Aug 19, 2024 08:04AM Processa Pharmaceuticals Inc. (PCSA) Reports Positive Preclinical Data for NGC-Iri
Aug 19, 2024 06:40AM Processa Pharmaceuticals (PCSA) PT Lowered to $6 at H.C. Wainwright
Jul 30, 2024 08:00AM Processa Pharmaceuticals Inc. (PCSA) Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
Jul 17, 2024 08:00AM Processa Pharmaceuticals Inc. (PCSA) Appoints Russell L. Skibsted as CFO
Jun 11, 2024 08:20AM Processa Pharmaceuticals Inc. (PCSA) Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer